BUSINESS● LOWJul 13 · Jul 13, 2026, 1:47 PM
TG Therapeutics (TGTX) Gains as Its Key Drug Exceeded Expectations
Yahoo Finance
TG Therapeutics (TGTX) experienced gains in its stock value. This increase is attributed to the performance of its key drug, which surpassed expectations.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS20m agoBlackRock's Rick Rieder sees 'historic' opportunity in high-quality bondsCNBCBUSINESS25m agoFidelity D&D Bancorp GAAP EPS of $1.53, revenue of $27.93MSeeking Alpha Tech